Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 211 results for "zydus group cadila healthcare"

Zydus to make presentation on Saroglitazar at Keystone Symposium
Business Standard India

Zydus Cadila to make presentation on Saroglitazar at Keystone ...

AHMEDABAD: Zydus Cadila group will be making an oral presentation on Saroglitazar, a novel compound under development for treatment in Non-alcoholic Steatohepatitis (NASH), at the Keystone Symposium on Liver Metabolism and Non-alcoholic Fatty Liver ... Times of India, 3 weeks ago

1 images for "zydus group cadila healthcare"

Business Standard India, 3 weeks ago
Indian Express

CADILA HEALTHCARE : Torrent, Cadila among donors to Cong, NCP

Ahmedabad: The Torrent group and Cadila Healthcare were among the top donors from Gujarat to have made donations to Congress and NCP ahead of 2014 Lok Sabha elections, a report by advocacy group Association for Democratic Reforms (ADR) said. The ...
 4 Traders2 months ago Zydus, Torrent among top donors to Cong, NCP in 2014 elections  Hindu Business Line2 months ago Torrent Group & Cadila Healthcare among top political donors from Gujarat during 2013-14  Indian Express2 months ago Torrent Group, Cadila Healthcare among top political donors from Gujarat; BJP only defaulter  Financial Express2 months ago

Buy Cadila Healthcare; target Rs 1727: Firstcall Research

Firstcall Research's report on Cadila Healthcare For the 3rd quarter ended Dec 31st, 2014, Zydus Cadila reported Net sales of Rs 21894.60 mn, up by 16.98% from Rs. 18716.90 mn in the corresponding quarter of the previous year on a consolidated ...
 Moneycontrol.com1 week ago Buy Cadila Healthcare; target of Rs 1715: Firstcall  Moneycontrol.com2 months ago

Zydus Cadila Net Profit up by 52% in Q3

For the third quarter ended 31st December 2014, Cadila Healthcare Limited registered a Net Profit of Rs. 282 crores, up by 52% from Rs. 186 crores in the corresponding period last year. The company registered a Total Income from Operations of Rs.
 FiercePharma2 weeks ago

Cadila Healthcare net jumps by 52% in Q3 to Rs. 282 cr

Cadila Healthcare, a Rs. 7,200 crore pharma major from Ahmedabad, has posted impressive financial performance during the third quarter ended December 2014 and its consolidated net profit went up sharply by 51.6 per cent to Rs. 282 crore from Rs. 186 ...
 PharmaBiz2 weeks ago Cadila Healthcare bucks trend on strong Q3 earnings  Capital Market3 weeks ago

Cadila recalls 19,536 bottles of cough treatment drug in US

dia | New Delhi January 8, 2015 Last Updated at 18:45 IST Drug firm Cadila Healthcare is voluntarily recalling 19,536 bottles of benzonatate capsules, used to treat coughs, in the US due to "wet and/or leaking capsules". According to a notification ...
 Business Standard India1 month ago Cadila Healthcare recalls 19,536 bottles of cough treatment drug in US  Economic Times1 month ago

Cadila Healthcare advances despite recalling cough treatment drug in US

Cadila Healthcare is currently trading at Rs. 1705.65, up by 59.40 points or 3.61% from its previous closing of Rs. 1646.25 on the BSE. The scrip opened at Rs. 1662.35 and has touched a high and low of Rs. 1717.95 and Rs. 1662.35 respectively. So ...
 Arihant Capital1 month ago

Zydus completes single rising dose Phase I studies for its oral HIF inhibitor, ZYAN1 for treating Anemia and initiates multiple dosing studies

Details Category: Small Molecules Published on Monday, 16 February 2015 12:51 Hits: 46 ZYAN1 is an orally bioavailable hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor, designed to increase the natural production of erythropoietin ...
 PipelineReview2 weeks ago Zydus begins Phase - III study of Saroglitazar in NASH, a liver disease caused by obesity, diabetes and lipid disorders  PipelineReview1 month ago
Business Standard India

Capital International in talks to buy stake in Mankind Pharma

Secondary private equity transactions seem to be on the rise in India's healthcare space. Capital International, a global private equity (PE) fund, is learnt to be in talks to acquire a 11 per cent stake in Delhi-based Mankind Pharma for Rs ...
 Business Standard India2 weeks ago
Financial Express

The Gujarat Model: Is it the way forward?

Gujarat has done very well in some sectors but with its health indicators still lagging behind, will it be the blueprint for the rest of India? By Raelene Kambli Sickle Cell Anemia Control Programme Gujarat's model of development has been ...
 Financial Express1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus group cadila healthcare
Get updated on latest news & your favorite topics right in your inbox!
More     Less